Efficacy and Safety of Ultra Small Dose Decitabine for the Lower Risk MDS Patients With Transfusion Dependent
Condition(s):Myelodysplastic SyndromesLast Updated:February 7, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Myelodysplastic SyndromesLast Updated:February 7, 2017Unknown status
Condition(s):Liver Metastasis; Colorectal CancerLast Updated:October 27, 2017Completed
Condition(s):Mesothelioma; Malignant Mesothelioma (MM); Early-stage Mesothelioma; Subclinical Mesothelioma; BRCA1-Associated Protein-1 (BAP1) Mutations; Early-stage BAP1-associated MalignanciesLast Updated:November 29, 2023Not yet recruiting
Condition(s):HealthyLast Updated:September 7, 2023Recruiting
Condition(s):Relapsed Acute Myeloid LeukemiaLast Updated:December 28, 2022Completed
Condition(s):Peripheral Blood Stem Cell TransplantationLast Updated:October 20, 2020Recruiting
Condition(s):Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Acute Myeloid LeukemiaLast Updated:September 5, 2023Completed
Condition(s):Myelodysplastic Syndrome; Acute Myeloid LeukemiaLast Updated:November 20, 2015Unknown status
Condition(s):Leukemia, Lymphoblastic, Acute; Leukemia, Myeloid Acute; Hematopoetic MyelodysplasiaLast Updated:October 15, 2018Completed
Condition(s):Childhood Solid Tumor; Childhood Lymphoma; Relapsed Cancer; Refractory Cancer; Adult Solid Tumor; Adult LymphomaLast Updated:January 31, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.